ArticleJournal of Korean medical science2026
Prescription Trends of Initial Antihypertensive Medications Among Presumed Treatment-Naïve Individuals in Korea: A Retrospective Analysis.
Article in Journal of Korean medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundHypertension is a major global health concern, closely linked to cardiovascular disease risks. This study assesses prescribing trends for initial antihypertensive therapy in South Korea, with a particular focus on the shift towards combination therapies, including fixed-dose combinations, as advocated by recent guidelines.
methodsWe retrospectively analyzed data from 59,950 presumed treatment-naïve hypertension patients without significant comorbidities, sourced from the National Patient Sample of the Health Insurance Review and Assessment Service, spanning 2009 to 2020. The study examined the prevalence of monotherapy versus combination therapy and the preferred classes of antihypertensive drugs.
resultsThe analysis revealed that 55.7% of patients received monotherapy, while 44.3% were initiated on combination therapy. Notably, 87.3% of the combination therapy cohort were prescribed fixed-dose combinations. The study observed a consistent increase in the use of fixed-dose combinations and a notable preference for angiotensin receptor blocker (ARB) and ARB/calcium channel blocker regimens over time. Factors such as age, sex, and specific comorbidities influenced the likelihood of receiving combination therapy.
conclusionThe findings highlight a progressive shift towards combination antihypertensive therapies, particularly fixed-dose combinations, among presumed treatment-naïve patients in South Korea. This trend reflects a broader move in clinical practice towards more aggressive treatment strategies recommended by current hypertension guidelines. The study underscores the importance of personalized treatment approaches, taking into consideration individual patient characteristics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.